4.8 Article

Ultramixing: A Simple and Effective Method To Obtain Controlled and Stable Dispersions of Graphene Oxide in Cell Culture Media

Journal

ACS APPLIED MATERIALS & INTERFACES
Volume 11, Issue 8, Pages 7695-7702

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/acsami.8b18304

Keywords

carbon nanomaterials; quantum dots; complexes; corona; dispersibility

Funding

  1. EU GRAPHENE Flagship project from the Agence Nationale de la Recherche (ANR) through the LabEx project Chemistry of Complex Systems [696656, 785219, ANR-10-LABX-0026_CSC]
  2. Centre National de la Recherche Scientifique (CNRS)
  3. International Center for Frontier Research in Chemistry (icFRC)
  4. JST PRESTO
  5. JSPS KAKENHI (Science of Atomic Layers) [16H00915]
  6. Grants-in-Aid for Scientific Research [16H00915] Funding Source: KAKEN

Ask authors/readers for more resources

The last decade has seen an increase in the application of graphene oxide (GO) in the biomedical field. GO has been successfully exploited for its ability to deliver many kinds of drugs into target cells. However, GO toxicity assessment is still controversial. Several studies have demonstrated that GO protein coating is crucial to alleviate the material's toxicity. Besides, coronation leads to the formation of big agglomerates, reducing the cellular uptake of the material and thus its therapeutic efficiency. In this work, we propose a simple and efficient method based on rapid (ultra-turrax, UT) mixing to control protein corona formation. Using the UT protocol, we were able to reduce GO agglomeration in the presence of proteins and obtain stable GO dispersions in cell culture media. By labelling GO with luminescent nanoparticles (quantum dots), we studied the GO internalization kinetic and efficiency. Comparing the classic and UT protocols, we found that the latter allows faster and more efficient internalization both in macrophages and HeLa cells without affecting cell viability. We believe that the use of UT protocol will be interesting and suitable for the preparation of next-generation GO-based drug-delivery platforms.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available